Syndax Pharmaceuticals, Inc.

General ticker "SNDX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.5B (TTM average)

Syndax Pharmaceuticals, Inc. follows the US Stock Market performance with the rate: 1.0%.

Estimated limits based on current volatility of 8.9%: low 9.81$, high 11.74$

Factors to consider:

  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [5.63$, 14.72$]
  • 2025-12-31 to 2026-12-31 estimated range: [3.89$, 10.43$]

Financial Metrics affecting the SNDX estimates:

  • Negative: Non-GAAP EPS, $ of -3.73 <= 0.04
  • Negative: negative Net income
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -17.81 <= 1.79
  • Positive: 22.52 < Shareholder equity ratio, % of 39.75 <= 43.26
  • Positive: Interest expense per share, $ of 0.06 <= 0.10

Similar symbols

Short-term SNDX quotes

2025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-072025-05-082025-05-091011121314
Price $

Long-term SNDX plot with estimates

51015202530Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−1−0.50
SNDXS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $23.68MM
Operating Expenses $151.76MM $229.95MM $363.35MM
Operating Income $-151.76MM $-229.95MM $-339.67MM
Non-Operating Income $2.42MM $20.59MM $20.91MM
Interest Expense $3.14MM $0.21MM $4.93MM
R&D Expense $118.50MM $163.03MM $241.65MM
Income(Loss) $-149.34MM $-209.36MM $-318.76MM
Profit(Loss)* $-143.75MM $-209.36MM $-318.76MM
Stockholders Equity $467.45MM $554.20MM $288.12MM
Inventory $4.25MM $0.00MM $0.37MM
Assets $497.24MM $612.88MM $724.82MM
Operating Cash Flow $-133.68MM $-160.60MM $-274.90MM
Capital expenditure $0.23MM $0.00MM $0.00MM
Investing Cash Flow $-186.19MM $117.61MM $-219.78MM
Financing Cash Flow $172.25MM $264.13MM $353.37MM
Earnings Per Share** $-2.37 $-2.98 $-3.72

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.